Previous 10 | Next 10 |
SALT LAKE CITY, July 30, 2019 (GLOBE NEWSWIRE) -- In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on target to achieve its financial goals for year 2019 despite the apparent n...
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...
Utah Medical Products (NASDAQ: UTMD ): Q1 GAAP EPS of $0.84. More news on: Utah Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SALT LAKE CITY, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- In the first calendar quarter (1Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with achieving its financial goals for year 2019 despite a negative comparison with 1Q 2018 results. ...
Utah Medical Products Inc. ( UTMD ) invents, innovates, designs, engineers, manufactures, and sells quality medical instruments to end-users and third party distributors for use in hospital and office settings. They also sell component parts to Original Equipment Manufacturers. Their four prod...
In June of 2015, I started a series of articles in which I highlight the stocks from the Dividend Champions list that have the highest and the lowest Percent Above Average Yield (PAAY) over the past year and over the past five years. PAAY is a measure of how much a stock is above (high PAAY, u...
Utah Medical Products (NASDAQ: UTMD ): Q4 Non-GAAP EPS of $0.94; GAAP EPS of $0.91. More news on: Utah Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SALT LAKE CITY, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Excluding a large favorable adjustment correcting the U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&P), Utah Medical Products, Inc. (Nasdaq: UTMD) concluded a solid year in 2018 i...
NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allegion PLC (NYSE:ALLE), Las Vegas Sands Corp. (NYSE:LVS), Select Income...
News, Short Squeeze, Breakout and More Instantly...
Utah Medical Products Inc. Company Name:
UTMD Stock Symbol:
NASDAQ Market:
Utah Medical Products Inc. Website:
2024-06-25 08:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024. Summary of results . The following is a summary com...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...